Nefazodone and Repotrectinib: Interaction Details
- Nefazodone
- Serzone
- Repotrectinib
- Augtyro
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Nefazodone and Repotrectinib interaction:
Repotrectinib
- Augtyro
What Happens When You Take Nefazodone With Repotrectinib
What can happen when they are taken together (rated Major)
Increased repotrectinib exposure and an increased risk of repotrectinib-related adverse effects
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
Repotrectinib should not be used together with strong that also inhibit . When a strong of both CYP3A and P-gp is given alongside repotrectinib, repotrectinib exposure can rise, and this may raise both the frequency and the severity of repotrectinib adverse reactions.
In interaction studies, giving repotrectinib with itraconazole (a strong CYP3A and P-gp inhibitor) raised repotrectinib (0 to inf) 5.9-fold and 1.7-fold. The CYP3A inhibitor should be stopped for 3 to 5 half-lives of that inhibitor before repotrectinib is started.1
The Nefazodone and Repotrectinib Interaction, Explained
Nefazodone can raise the amount of repotrectinib (Augtyro) in your body. Nefazodone, an antidepressant, slows down the liver enzyme () and the () that help clear repotrectinib. With less , more of the cancer medicine stays in your blood, which could make side effects like dizziness, trouble with balance or coordination, numbness or tingling, and tiredness stronger or more likely.
This is based on the drugs' known properties and a study with a similar blocking drug (itraconazole), not on a direct study with nefazodone. Please don't stop or change either medicine on your own. Talk with your pharmacist or doctor, who can review your options and manage this safely.
Mechanism: Nefazodone is a strong and also inhibits . Repotrectinib is a and P-gp , so is expected to increase its exposure. Neither drug's activation depends on this pathway, so the direction is increased repotrectinib exposure.
- Magnitude: With itraconazole (strong CYP3A/P-gp inhibitor), repotrectinib AUC0-inf rose 5.9-fold and 1.7-fold. Nefazodone-specific data are lacking.
- Evidence: Theoretical (extrapolated). Onset unspecified. Severity: major.
- Risk: Increased incidence and severity of repotrectinib adverse reactions (e.g., effects such as dizziness and ataxia, and others per labeling).
- Management: Avoid . If nefazodone was in use, discontinue it for 3 to 5 of its half-lives before starting repotrectinib. Consider an alternative antidepressant.
See the 1 reference behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Nefazodone and Repotrectinib Interact
The likely mechanism
of -mediated of repotrectinib; inhibition of -mediated efflux transport of repotrectinib
How to Manage the Nefazodone and Repotrectinib Interaction
Your care team will usually try to avoid using these two medicines together. If you take nefazodone, they may plan to have it stopped for a period of time (about 3 to 5 half-lives of nefazodone) before repotrectinib is started, or they may choose a different antidepressant.
- Do not stop or change either medicine on your own. Stopping an antidepressant suddenly can cause problems.
- Tell your pharmacist and prescriber about every medicine you take, including nefazodone.
- Report new or worsening side effects, such as dizziness, balance trouble, or numbness, to your care team promptly.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Nefazodone or Repotrectinib need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Literature Reports
1 report from the published literature. Each one is headed by the title of the published study it comes from.
What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.
-
Report 1 · Study title
Prescribing information: AUGTYRO oral capsules, repotrectinib oral capsules
In drug interaction studies, with itraconazole (a strong and ) raised repotrectinib (0 to inf) 5.9-fold and 1.7-fold.1
Nefazodone and Repotrectinib: Common Questions
How serious is the Nefazodone and Repotrectinib interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Nefazodone and Repotrectinib interaction managed?
Your care team will usually try to avoid using these two medicines together. If you take nefazodone, they may plan to have it stopped for a period of time (about 3 to 5 half-lives of nefazodone) before repotrectinib is started, or they may choose a different antidepressant. Do not stop or change either medicine on your own. Stopping an antidepressant suddenly can cause problems. Tell your pharmaci… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
Ask About the Nefazodone and Repotrectinib Interaction
Ask in your own words about taking Nefazodone and Repotrectinib together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (1)
- Product Information: AUGTYRO(TM) oral capsules, repotrectinib oral capsules. Bristol-Myers Squibb Company (per FDA), Princeton, NJ, 2023. DailyMed
Other Serious Interactions of Nefazodone and Repotrectinib
Also serious with Nefazodone
- ColchicineContraindicated
- SimvastatinContraindicated
- Dihydroergotamine InjectionContraindicated
- Dihydroergotamine Nasal SprayContraindicated
Also serious with Repotrectinib
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Nefazodone
- GrapefruitMajor
- St. John's WortMajor
- Activated CharcoalMajor
- LithiumMajor
- Vitamin EModerate
- GingerModerate
- TurmericModerate
- Black PepperModerate
- + 155 more
With Repotrectinib
- GrapefruitMajor
- St. John's WortMajor
- Activated CharcoalMajor
- WineMajor
- BeerMajor
- Siberian CockleburMajor
- Vitamin EModerate
- Vitamin AModerate
- + 182 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.